Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
1 finding from 1 review
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with moderate to severe pain up to 6 hours after the procedure · children undergoing surgery
1 finding from 1 review
Physician's assessment of global response of improvement, clear or excellent ‐ 6 weeks · people with atopic dermatitis
It is very uncertain whether tacrolimus 0.03% changes physician's assessment of global response of improvement, clear or… compared with corticosteroids (very low certainty).
1 finding from 1 review
Recovery long‐term Number of patients at least moderately better · patients with patellofemoral pain syndrome (symptoms > 1 month (3 studies); symptoms > 2 months (1 study); symptoms > 3 months (2…
It is very uncertain whether target of exercise: hip + knee changes recovery long‐term Number of patients at least moderately better compared with knee exercises (very low certainty).
1 finding from 1 review
Intervention not reported
At least 30% reduction in pain or equivalent (moderate) · adults with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Oral mucositis (moderate to severe) · Patients with osteosarcoma (bone cancer) receiving high-dose methotrexate, vincristine and leucovorin
1 finding from 1 review
Oral mucositis (moderate to severe). Not estimable - no participants had developed moderate or severe oral mucositis by the fourth day after chemotherapy when the data were reported (Zhang 2011, Analysis 4.2, subgroup…
1 study · 81 participants
GRADE not reported
Episodes of moderate/severe sore throat(subgroup of severely affected patients) Including as 1 episode the period post‐surgery) · Children with chronic/recurrent acute tonsillitis
1 finding from 1 review
Episodes of moderate/severe sore throat(subgroup of moderately affected patients) Not including as 1 episode the period post‐surgery · Children with chronic/recurrent acute tonsillitis
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · people with asthma
Subcutaneous omalizumab + steroid probably leads to lower number of participants with at least one exacerbation Moderate to… compared with placebo + steroid (stable steroid) (moderate certainty).
1 finding from 1 review
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · adults with neuropathic pain (Trigeminal neuralgia, painful diabetic neuropathy, chronic post stroke pain)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · Adults with cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
OHSS · subfertile women
GnRH agonist probably leads to lower OHSS (mild, moderate or severe): overall risk compared with HCG (moderate certainty).
1 finding from 1 review
Moderate or severe OHSS · subfertile women
GnRH agonist probably leads to lower OHSS (moderate or severe): overall risk compared with HCG (moderate certainty).
1 finding from 1 review
OHSS (mild, moderate or severe) in women at high risk of OHSS · subfertile women
GnRH agonist probably leads to lower OHSS (mild, moderate or severe) in women at high risk of OHSS compared with HCG (moderate certainty).
1 finding from 1 review
Physical health behaviour moderate or vigorous physical activity · people with severe mental disorders
1 finding from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
Nalbuphine may leads to lower number of patients with moderate/severe pain (1 hour postoperatively) compared with placebo (low certainty).
2 findings from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
1 finding from 1 review
Number of patients with moderate/severe pain (1 hour postoperatively) · children undergoing surgery
1 finding from 1 review